US Stock MarketDetailed Quotes

VRAX Virax Biolabs

Watchlist
  • 2.1000
  • +0.3700+21.39%
Close Dec 27 16:00 ET
  • 2.0400
  • -0.0600-2.86%
Post 20:01 ET
9.12MMarket Cap-0.80P/E (TTM)

About Virax Biolabs Company

Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.

Company Profile

SymbolVRAX
Company NameVirax Biolabs
Listing DateJul 21, 2022
Issue Price5.00
Founded2013
CEOMr. James Foster
MarketNASDAQ
Employees17
Fiscal Year Ends03-31
AddressBo'Ness Road Newhouse
CityLanarkshire
ProvinceScotland
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeML1 5UH
Phone44-20-7788-7414

Company Executives

  • Name
  • Position
  • Salary
  • James Foster
  • Chief Executive Officer and Chairman of the Board
  • 650.80K
  • Jason Davis
  • Chief Financial Officer
  • 625.12K
  • Dr. Nigel McCracken
  • Chief Operating Officer and Director
  • 300.14K
  • Yair Erez
  • Independent Director
  • 100.30K
  • Nelson M. Haight
  • Independent Director
  • 100.30K
  • Evan Norton
  • Independent Director
  • 100.30K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.